{"id":"step-1","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Hypoglycemia"},{"rate":"10-20%","effect":"Weight gain"},{"rate":"null","effect":"Allergic reactions"}]},"_chembl":null,"_dailymed":{"setId":"ae406389-0f83-d5c8-bd2f-56075e57453a","title":"NICOTINE TRANSDERMAL SYSTEM STEP 1 (NICOTINE) PATCH, EXTENDED RELEASE NICOTINE TRANSDERMAL SYSTEM STEP 2 (NICOTINE) PATCH, EXTENDED RELEASE NICOTINE TRANSDERMAL SYSTEM STEP 3 (NICOTINE) PATCH, EXTENDED RELEASE [RUGBY LABORATORIES]"},"mechanism":{"_ai_source":"groq-llama-8b","explanation":"It works by stimulating glucose uptake in the muscles and suppressing glucose production in the liver. Step 1 is administered via subcutaneous injection and has a rapid onset of action.","oneSentence":"Step 1 is a recombinant human insulin used to lower blood glucose levels in people with diabetes.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T05:31:13.234Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Diabetes mellitus, type 1"},{"name":"Diabetes mellitus, type 2"}]},"trialDetails":[{"nctId":"NCT07157982","phase":"NA","title":"Living With Multimorbidity: Care Coordination and Symptom Management Program (COORDINATE)","status":"NOT_YET_RECRUITING","sponsor":"Johns Hopkins University","startDate":"2026-05","conditions":"Multimorbidity","enrollment":10},{"nctId":"NCT05490771","phase":"PHASE2","title":"Testing Copanlisib as a Potential Targeted Treatment in Cancers With PIK3CA Mutations (MATCH-Subprotocol Z1F)","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2018-06-20","conditions":"Advanced Lymphoma, Advanced Malignant Solid Neoplasm, Hematopoietic and Lymphatic System Neoplasm","enrollment":35},{"nctId":"NCT07494240","phase":"NA","title":"Effects of Changes in Driving Pressure on Intraoperative Pulmonary Dynamic Compliance and PaO₂/FiO₂ Ratio in Laparoscopic Sleeve Gastrectomy","status":"NOT_YET_RECRUITING","sponsor":"Beni-Suef University","startDate":"2026-04-15","conditions":"Dynamic Lung Compliance","enrollment":46},{"nctId":"NCT07495319","phase":"NA","title":"Influence of Tamponade on Retinal Shift in Eyes Undergoing Vitrectomy for Rhegmatogenous Retinal Detachment: A Comparison of Gas Versus Silicone Oil in a Pakistani Population","status":"COMPLETED","sponsor":"Wardah","startDate":"2025-04-15","conditions":"Retinal Detachment Rhegmatogenous, Vitrectomy, Retina Disorder","enrollment":78},{"nctId":"NCT06747221","phase":"NA","title":"Implementation Science to Enhance HIV Testing Services During Emergency Care in Kenya","status":"NOT_YET_RECRUITING","sponsor":"Rhode Island Hospital","startDate":"2026-06-01","conditions":"HIV","enrollment":184},{"nctId":"NCT07491302","phase":"PHASE2","title":"Thumb Base Osteoarthritis: Ultrasound-guided Platelet-rich Plasma Versus Placebo Injection","status":"NOT_YET_RECRUITING","sponsor":"Goed Medisch Centrum","startDate":"2026-03","conditions":"Thumb Osteoarthritis","enrollment":88},{"nctId":"NCT07494357","phase":"NA","title":"Effects of Dual Task-Oriented Circuit Training on Walking Recovery in Sub-acute Stroke","status":"NOT_YET_RECRUITING","sponsor":"Universitas Padjadjaran","startDate":"2026-04-01","conditions":"Stroke, Cerebrovascular","enrollment":36},{"nctId":"NCT07181941","phase":"PHASE1, PHASE2","title":"Response-Based Dose Reduction of Linvoseltamab in the Treatment of Relapsed, Refractory, or Triple-Class Relapsed/Refractory Multiple Myeloma","status":"RECRUITING","sponsor":"Fred Hutchinson Cancer Center","startDate":"2026-03-24","conditions":"Recurrent Multiple Myeloma, Refractory Multiple Myeloma","enrollment":30},{"nctId":"NCT07495579","phase":"PHASE2","title":"Lenvatinib or Regorafenib for Advanced Hepatocellular Carcinoma After Immunotherapy (REVIVE)","status":"NOT_YET_RECRUITING","sponsor":"Asan Medical Center","startDate":"2026-04","conditions":"Hepatocellular Carcinoma (HCC)","enrollment":146},{"nctId":"NCT02858323","phase":"","title":"Complement (C1q) Binding to HLA Antibodies in a Solid-phase Immunoassay and Clinical Effect on Platelet Transfusion","status":"COMPLETED","sponsor":"National Institutes of Health Clinical Center (CC)","startDate":"2016-07-27","conditions":"Thrombocytopenia, Platelet Transfusion Refractoriness","enrollment":68},{"nctId":"NCT01861314","phase":"PHASE1","title":"Bortezomib, Sorafenib Tosylate, and Decitabine in Treating Patients With Acute Myeloid Leukemia","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2013-07-03","conditions":"Acute Myeloid Leukemia, Acute Myeloid Leukemia Post Cytotoxic Therapy, Recurrent Adult Acute Myeloid Leukemia","enrollment":15},{"nctId":"NCT04236739","phase":"PHASE3","title":"Comparing Clinical Outcomes of the One-step Cartilage Transplantation in Cartilage Defects of the Knee With Conservative Treatment","status":"COMPLETED","sponsor":"R.J.H. Custers","startDate":"2019-07-23","conditions":"Cartilage Damage","enrollment":60},{"nctId":"NCT04092283","phase":"PHASE3","title":"Testing the Addition of an Antibody to Standard Chemoradiation Followed by the Antibody for One Year to Standard Chemoradiation Followed by One Year of the Antibody in Patients With Unresectable Stage III Non-Small Cell Lung Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2020-04-29","conditions":"Recurrent Lung Non-Small Cell Carcinoma, Stage III Lung Cancer AJCC v8, Stage IIIA Lung Cancer AJCC v8","enrollment":660},{"nctId":"NCT06907472","phase":"NA","title":"Diabetes Management for Primary Healthcare Centers.","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Abuja","startDate":"2025-09-15","conditions":"Type 2 Diabetes Mellitus (T2DM)","enrollment":106},{"nctId":"NCT07497165","phase":"","title":"Epunamin Combined With DECP for Relapsed/Refractory Multiple Myeloma","status":"RECRUITING","sponsor":"Shanxi Bethune Hospital","startDate":"2025-11-01","conditions":"Relapsed/Refractory Multiple Myeloma (RRMM), Multiple Myeloma","enrollment":48},{"nctId":"NCT06058377","phase":"PHASE3","title":"Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2023-11-27","conditions":"Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, HER2-Negative Breast Carcinoma","enrollment":3680},{"nctId":"NCT07328490","phase":"PHASE1, PHASE2","title":"Bispecific T-Cell Engager Tarlatamab and TROP2 Targeted Antibody Drug Conjugate Sacituzumab Govitecan in Previously Treated Extensive-Stage Small Cell Lung Cancer and Extrapulmonary Neuroendocrine Cancer","status":"NOT_YET_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2026-04-01","conditions":"Extensive-Stage Small Cell Lung Cancer, Extrapulmonary Neuroendocrine Carcinoma, Small Cell Carcinoma","enrollment":120},{"nctId":"NCT06496425","phase":"NA","title":"Inspiring Seniors Towards Exercise Promotion to Protect Cognition","status":"RECRUITING","sponsor":"Emory University","startDate":"2024-05-15","conditions":"Alzheimer Disease, Physical Activity","enrollment":80},{"nctId":"NCT07458100","phase":"NA","title":"The STEP-MIED Trial: Digital Stepped-Care for Emotional Disorders","status":"RECRUITING","sponsor":"Peking University","startDate":"2026-03","conditions":"Emotional Disorders, Depressive Disorder, Anxiety Disorders","enrollment":464},{"nctId":"NCT02465060","phase":"PHASE2","title":"Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2015-08-17","conditions":"Advanced Lymphoma, Advanced Malignant Solid Neoplasm, Bladder Carcinoma","enrollment":6452},{"nctId":"NCT04310007","phase":"PHASE2","title":"Testing the Addition of the Pill Chemotherapy, Cabozantinib, to the Standard Immune Therapy Nivolumab Compared to Standard Chemotherapy for Non-small Cell Lung Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2020-07-13","conditions":"Metastatic Lung Non-Squamous Non-Small Cell Carcinoma, Recurrent Lung Non-Squamous Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8","enrollment":117},{"nctId":"NCT06311214","phase":"PHASE2","title":"Personalized Antibody-Drug Conjugate Therapy Based on RNA and Protein Testing for the Treatment of Advanced or Metastatic Solid Tumors (The ADC MATCH Screening and Treatment Trial)","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2025-03-18","conditions":"Advanced Malignant Solid Neoplasm, Metastatic Malignant Solid Neoplasm","enrollment":500},{"nctId":"NCT07494916","phase":"NA","title":"Effects of Functional Task Training on Muscle Health and Function in Older Adults With Sarcopenia","status":"ACTIVE_NOT_RECRUITING","sponsor":"Universidad de Granada","startDate":"2026-02-02","conditions":"Sarcopenia, Aging, Physical Functional Performance","enrollment":30},{"nctId":"NCT06883942","phase":"","title":"Pilot Study on the Evaluation of the Functionality, Safety and Reliability of New Tripping Devices for Lower Limbs.","status":"COMPLETED","sponsor":"Fondazione Don Carlo Gnocchi Onlus","startDate":"2024-02-06","conditions":"Lower Limb Amputation, Slip Perturbations, Fall Risk","enrollment":8},{"nctId":"NCT06969859","phase":"NA","title":"Pulsed Electro-Magnetic Field Therapy for Treatment of Midportion Achilles Tendinopathy","status":"RECRUITING","sponsor":"Chinese University of Hong Kong","startDate":"2025-10-15","conditions":"Mid-portion Achilles Tendinopathy","enrollment":200},{"nctId":"NCT07470463","phase":"","title":"Evaluation of One-Shot Vision Differential Diagnosis (OSVDE) and Multi-Step Conversational Non-Inferiority (MSCNE) in AI Medical Interviewing","status":"RECRUITING","sponsor":"Magic Health Inc. (d.b.a. Nolla Health)","startDate":"2026-03-19","conditions":"Differential Diagnosis, Diagnostic Accuracy","enrollment":30},{"nctId":"NCT07492810","phase":"NA","title":"The Effect of Peer Video Modeling and 3D Jaw Video Modeling Training on Oral Health and Toothbrushing Skills in Children With Autism","status":"COMPLETED","sponsor":"Ministry of Health, Turkey","startDate":"2021-09-20","conditions":"Autism Spectrum Disorder (ASD, Dental Health, Oral Hygiene, Oral Health","enrollment":120},{"nctId":"NCT07492017","phase":"NA","title":"The Effect of Puzzles on Nursing Students' Learning to Intramuscular Injection: A Randomized Controlled Study","status":"COMPLETED","sponsor":"Trakya University","startDate":"2025-02-09","conditions":"Learning Concepts and Skills","enrollment":140},{"nctId":"NCT07171203","phase":"PHASE1","title":"Neoadjuvant Imatinib and Fampridine in KIT Mutant Gastrointestinal Stromal Tumor","status":"RECRUITING","sponsor":"University of California, San Diego","startDate":"2026-06","conditions":"Gastrointestinal Stromal Tumors","enrollment":18},{"nctId":"NCT07452198","phase":"PHASE3","title":"A Study of GR1803 Injection Versus Daratumumab, Pomalidomide, and Dexamethasone (DPd) in Participants With Relapsed or Refractory Multiple Myeloma","status":"RECRUITING","sponsor":"Genrix (Shanghai) Biopharmaceutical Co., Ltd.","startDate":"2026-03-09","conditions":"Multiple Myeloma","enrollment":358},{"nctId":"NCT07489625","phase":"EARLY_PHASE1","title":"Hydromorphone With Electroacupuncture and Ear Acupoint Pressing for Refractory Cancer Pain","status":"NOT_YET_RECRUITING","sponsor":"Qinghai Red Cross Hospital","startDate":"2026-03-07","conditions":"Refractory Cancer Pain, Cancer Pain","enrollment":30},{"nctId":"NCT07491796","phase":"NA","title":"Comparison of One-Step and Two-Step Light Curing of Bonding Agents and Composite in Orthodontics","status":"COMPLETED","sponsor":"Shaheed Zulfiqar Ali Bhutto Medical University","startDate":"2022-05-04","conditions":"Orthodontic Treatment, Bracket Failure","enrollment":64},{"nctId":"NCT03458026","phase":"NA","title":"Move Your Spondyl \" Better Live Its Rheumatism With the Physical Activity \"","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire de Nice","startDate":"2018-03-22","conditions":"Spondyloarthritis","enrollment":108},{"nctId":"NCT04464434","phase":"PHASE4","title":"Upfront Autologous HSCT Versus Immunosuppression in Early Diffuse Cutaneous Systemic Sclerosis","status":"COMPLETED","sponsor":"UMC Utrecht","startDate":"2020-09-17","conditions":"Systemic Sclerosis, Systemic Scleroses, Diffuse, Scleroderma","enrollment":60},{"nctId":"NCT07380490","phase":"NA","title":"Comparing Two PFO Closure Devices in Adults With Previous Stroke or TIA","status":"NOT_YET_RECRUITING","sponsor":"Giuseppe Tarantini","startDate":"2026-04","conditions":"Patent Foramen Ovale, Stroke, Transient Ischemic Attack (TIA)","enrollment":1260},{"nctId":"NCT07095465","phase":"PHASE3","title":"Phase 3, Open Label Extension Study of ACP-204 in Lewy Body Dementia Psychosis","status":"ENROLLING_BY_INVITATION","sponsor":"ACADIA Pharmaceuticals Inc.","startDate":"2025-11-14","conditions":"Lewy Body Dementia Psychosis","enrollment":126},{"nctId":"NCT03288207","phase":"NA","title":"Tailoring Mobile Health Technology to Reduce Obesity and Improve Cardiovascular Health in Resource-Limited Neighborhood Environments","status":"RECRUITING","sponsor":"National Heart, Lung, and Blood Institute (NHLBI)","startDate":"2018-06-21","conditions":"Obesity","enrollment":325},{"nctId":"NCT07056426","phase":"NA","title":"Comparison of ESWT and Deep Tissue Massage in Individuals With Medial Tibial Stress Syndrome","status":"COMPLETED","sponsor":"Ankara Yildirim Beyazıt University","startDate":"2025-06-02","conditions":"Medial Tibial Stress Syndrome","enrollment":22},{"nctId":"NCT06854185","phase":"NA","title":"Feasibility of the Paso Program for Patients With Metabolic Dysfunction Associated Steatotic Liver Disease","status":"ACTIVE_NOT_RECRUITING","sponsor":"Baylor College of Medicine","startDate":"2025-02-05","conditions":"Metabolic Dysfunction Associated Steatotic Liver Disease, Overweight (BMI &gt; 25), Metabolic Syndrome","enrollment":50},{"nctId":"NCT06089954","phase":"NA","title":"Penn Medicine Biobank Return of Results Program","status":"ENROLLING_BY_INVITATION","sponsor":"Abramson Cancer Center at Penn Medicine","startDate":"2023-10-20","conditions":"Genetic Disease, Cancer, Cardiovascular Diseases","enrollment":2500},{"nctId":"NCT04251728","phase":"NA","title":"Effects of AMPS on Cardiovascular and Functional Variables in Patients With Parkinson's Disease","status":"COMPLETED","sponsor":"Universidad Católica del Maule","startDate":"2022-03-30","conditions":"Parkinson Disease","enrollment":40},{"nctId":"NCT07151690","phase":"PHASE2","title":"BCMA/CD3 Bispecific Antibody Treatment for Newly Diagnosed Amyloidosis","status":"RECRUITING","sponsor":"Institute of Hematology & Blood Diseases Hospital, China","startDate":"2025-09-04","conditions":"Systemic Light Chain Amyloidosis","enrollment":21},{"nctId":"NCT05046171","phase":"PHASE1, PHASE2","title":"Decreasing Polypharmacy in Older Adults With Curable Cancers Trial","status":"COMPLETED","sponsor":"University of Rochester","startDate":"2022-06-14","conditions":"Cancer","enrollment":51},{"nctId":"NCT03835767","phase":"PHASE2","title":"Food-Specific and Component IgE Threshold Levels That Predict Food Allergy in People With Elevated Total Serum IgE Levels and Atopic Dermatitis","status":"RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2019-04-19","conditions":"Milk and/or Peanut Allergy","enrollment":200},{"nctId":"NCT07480876","phase":"NA","title":"Glyceryl Trinitrate Gel Phonophoresis on Planter Fasciiatis","status":"NOT_YET_RECRUITING","sponsor":"Cairo University","startDate":"2026-04-30","conditions":"Planter Fasciitis","enrollment":80},{"nctId":"NCT06235567","phase":"PHASE1, PHASE2","title":"Dextenza Versus Topical Steroid Eye Drops for Postoperative Management Following Corneal Crosslinking","status":"ENROLLING_BY_INVITATION","sponsor":"Maanasa Indaram, MD","startDate":"2025-04-11","conditions":"Keratoconus","enrollment":20},{"nctId":"NCT05433350","phase":"PHASE2, PHASE3","title":"Pharmacokinetic, Efficacy, Safety and Tolerability Study of a Single Dose of Acoziborole in g-HAT Paediatric Patients","status":"RECRUITING","sponsor":"Drugs for Neglected Diseases","startDate":"2022-07-09","conditions":"Trypanosomiasis, African, Trypanosoma Brucei Gambiense; Infection, Sleeping Sickness","enrollment":35},{"nctId":"NCT06335979","phase":"PHASE1","title":"An Ascending Dose Study of PIT565 in Participants With Systemic Lupus Erythematosus (SLE).","status":"RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2024-10-08","conditions":"Systemic Lupus Erythematosus, SLE","enrollment":54},{"nctId":"NCT06156293","phase":"NA","title":"Prevention of Insomnia Using a Stepped Care Model in Adults","status":"RECRUITING","sponsor":"Chinese University of Hong Kong","startDate":"2023-12-01","conditions":"Sleep Disturbance","enrollment":1016},{"nctId":"NCT07001748","phase":"PHASE2, PHASE3","title":"Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity","status":"RECRUITING","sponsor":"ECOG-ACRIN Cancer Research Group","startDate":"2025-08-19","conditions":"Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Peritoneal Carcinomatosis","enrollment":148},{"nctId":"NCT07194902","phase":"NA","title":"HIV Self-testing for Partners of HIV-uninfected Postpartum Women","status":"RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2026-03-19","conditions":"HIV Self-testing, Male Partners of HIV-negative Postpartum Women, PrEP Uptake","enrollment":120},{"nctId":"NCT06632652","phase":"NA","title":"Telenursing System by Providing Health Education and Lifestyle Modification Among Diabetic Patients in Bangladesh","status":"COMPLETED","sponsor":"Hiroshima University","startDate":"2024-10-26","conditions":"Diabetes Mellitus","enrollment":70},{"nctId":"NCT06676839","phase":"NA","title":"Effectiveness of the WHO ICOPE (Integrated Care for Older People) Program in Preventing Age-related Functional Decline (ICOPE Trial.Fr)","status":"RECRUITING","sponsor":"University Hospital, Toulouse","startDate":"2024-10-14","conditions":"Ageing","enrollment":1000},{"nctId":"NCT07487467","phase":"NA","title":"Autologous SVF Therapy for Type 2 Diabetes","status":"RECRUITING","sponsor":"Kaiser Clinic and Hospital","startDate":"2025-01-20","conditions":"Diabetes Mellitus, Type 2","enrollment":10},{"nctId":"NCT06788938","phase":"PHASE2","title":"Tarlatamab in Advanced Delta-like 3 (DLL3)-Expressing Tumors Including Neuroendocrine Neoplasms","status":"RECRUITING","sponsor":"Jonsson Comprehensive Cancer Center","startDate":"2025-03-21","conditions":"DLL3-expressing Tumors, Advanced Tumors","enrollment":29},{"nctId":"NCT07484464","phase":"NA","title":"Effects of the Otago Exercise Program on Balance, Endurance, and Motor Coordination in Children With Down Syndrome","status":"RECRUITING","sponsor":"Riphah International University","startDate":"2026-03-02","conditions":"Down Syndrome","enrollment":30},{"nctId":"NCT07484581","phase":"NA","title":"Effect of Wobble Board Exercises Versus Swiss Ball Exercises on Balance and Functional Stability of Stroke Patients","status":"NOT_YET_RECRUITING","sponsor":"Riphah International University","startDate":"2026-02-28","conditions":"Stroke","enrollment":38},{"nctId":"NCT07478107","phase":"","title":"Molecular Citology to Detect Free Cancer Cells in Peritoneal Fluid","status":"COMPLETED","sponsor":"University of Campania Luigi Vanvitelli","startDate":"2024-07-01","conditions":"Peritoneal Carcinomatosis","enrollment":108},{"nctId":"NCT07484373","phase":"NA","title":"Effects of Hip Abductor Strengthening Exercises in Patients With Piriformis Syndrome","status":"COMPLETED","sponsor":"Riphah International University","startDate":"2025-01-13","conditions":"Piriformis Syndrome","enrollment":48},{"nctId":"NCT07482917","phase":"NA","title":"Optimizing the Diagnostic Journey in Interstitial Lung Disease: The OPTIMIZE-ILD-1 Trial","status":"RECRUITING","sponsor":"Hospital de Granollers","startDate":"2026-03-09","conditions":"Interstitial Lung Disease (ILD), Suspected Interstitial Lung Disease, Fibrotic Interstitial Lung Disease","enrollment":92},{"nctId":"NCT06536361","phase":"NA","title":"Immersive Virtual Reality for Respiratory System Physical Examination Training Compared With Peer-Assisted Small-Group Practice: A Randomized Controlled Trial","status":"COMPLETED","sponsor":"Gazi University","startDate":"2024-05-20","conditions":"Nurse's Role, Nurse-Patient Relations, Exanimation","enrollment":76},{"nctId":"NCT07481578","phase":"NA","title":"Impact of Training Load on the Gut miCrobiome And Its Relation to exeRcise Performance, mUscle Phenotype, and markerS of Overreaching in Healthy Men","status":"RECRUITING","sponsor":"Stefan De Smet","startDate":"2024-10-07","conditions":"Exercise, Overreaching, Butyrate","enrollment":45},{"nctId":"NCT06451120","phase":"PHASE2","title":"Platelet Rich Plasma Injections In Young And Old Human Subjects","status":"RECRUITING","sponsor":"University of California, San Francisco","startDate":"2024-06-01","conditions":"Osteoarthritis, Articular Cartilage, Musculoskeletal Disorders","enrollment":60},{"nctId":"NCT06189391","phase":"PHASE1","title":"A Study to Evaluate MK-1045 (CN201) in Participants With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma (MK-1045-001/CN201-101)","status":"RECRUITING","sponsor":"MSD R&D (China) Co., Ltd.","startDate":"2021-03-16","conditions":"Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma","enrollment":100},{"nctId":"NCT06406114","phase":"PHASE2","title":"Optimizing the Diagnostic Approach to Cephalosporin Allergy Testing","status":"RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2025-05-05","conditions":"Drug Allergy, Cephalosporin Allergy, Drug Hypersensitivity","enrollment":300},{"nctId":"NCT03588299","phase":"PHASE1, PHASE2","title":"Study to Test the Safety and How Well Patients With Severe Hemophilia A Respond to Treatment With BAY 2599023 (DTX 201), a Drug Therapy That Delivers a Healthy Version of the Defective Factor VIII Gene Into the Nucleus of Liver Cells Using an Altered, Non-infectious Virus (AAV) as a \"Shuttle\"","status":"ACTIVE_NOT_RECRUITING","sponsor":"Bayer","startDate":"2018-11-07","conditions":"Hemophilia A","enrollment":11},{"nctId":"NCT07484087","phase":"NA","title":"Ablation Compare With Surgery for Early Breast Cancer","status":"RECRUITING","sponsor":"Peking University People's Hospital","startDate":"2026-01-01","conditions":"Breast Cancer, Early Stage, Hormone Receptor Positive","enrollment":264},{"nctId":"NCT06489964","phase":"NA","title":"Addressing Unfunded Vaccines Through a Co-payment Mechanism in Pharmacies","status":"RECRUITING","sponsor":"Canadian Immunization Research Network","startDate":"2025-10-23","conditions":"Preventable Disease, Vaccine","enrollment":600},{"nctId":"NCT06124404","phase":"PHASE2","title":"Step 1 of A Two-step Trial to Evaluate the Effectiveness and Safety of Remimazolam Besylate for Sedation in ICU Patients","status":"COMPLETED","sponsor":"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","startDate":"2022-04-08","conditions":"Mechanically Ventilated Patients","enrollment":36},{"nctId":"NCT02720094","phase":"PHASE2, PHASE3","title":"Injectable Cabotegravir Compared to TDF/FTC For PrEP in HIV-Uninfected Men and Transgender Women Who Have Sex With Men","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2016-12-19","conditions":"HIV Infections","enrollment":4570},{"nctId":"NCT07483866","phase":"NA","title":"The Effectiveness of a Virtual Reality-based Educational Intervention on Anxiety Symptoms, Pain Levels, and Physiological Indicator Outcomes in Surgical Patients","status":"NOT_YET_RECRUITING","sponsor":"Jia-Ling Wang","startDate":"2026-03-01","conditions":"Preoperative Anxiety","enrollment":200},{"nctId":"NCT05828511","phase":"PHASE1, PHASE2","title":"A Window of Opportunity Trial to Learn if Linvoseltamab is Safe and Well Tolerated, and How Well it Works in Adult Participants With Recently Diagnosed Multiple Myeloma Who Have Not Already Received Treatment","status":"RECRUITING","sponsor":"Regeneron Pharmaceuticals","startDate":"2023-12-19","conditions":"Multiple Myeloma","enrollment":149},{"nctId":"NCT07363642","phase":"PHASE3","title":"Phase 3b Study in Patients With Severe Asthma Treated With Tezepelumab","status":"RECRUITING","sponsor":"AstraZeneca","startDate":"2026-01-28","conditions":"Severe Asthma","enrollment":400},{"nctId":"NCT06105437","phase":"NA","title":"Implementation of a Multifactorial Falls Prevention Intervention in Older Community-dWElling peRsons","status":"COMPLETED","sponsor":"KU Leuven","startDate":"2023-01-01","conditions":"Falls Prevention, Implementation, Older People","enrollment":550},{"nctId":"NCT05083169","phase":"PHASE3","title":"A Study of Teclistamab in Combination With Daratumumab Subcutaneously (SC) (Tec-Dara) Versus Daratumumab SC, Pomalidomide, and Dexamethasone (DPd) or Daratumumab SC, Bortezomib, and Dexamethasone (DVd) in Participants With Relapsed or Refractory Multiple Myeloma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Janssen Research & Development, LLC","startDate":"2021-10-14","conditions":"Multiple Myeloma","enrollment":587},{"nctId":"NCT06910475","phase":"NA","title":"Physical Exercise and Biomolecular Analysis to Reduce Uremic Toxins in Chronic Kidney Disease: An Exploratory Study","status":"ENROLLING_BY_INVITATION","sponsor":"Catholic University of Brasília","startDate":"2025-04-01","conditions":"Kidney Disease, Chronic, Kidney Failure Chronic","enrollment":1600},{"nctId":"NCT06735638","phase":"PHASE1","title":"Outside the Cage (OTC) Robotic Esophagectomy","status":"NOT_YET_RECRUITING","sponsor":"Centre hospitalier de l'Université de Montréal (CHUM)","startDate":"2027-01-01","conditions":"Esophageal Cancer","enrollment":31},{"nctId":"NCT07015944","phase":"NA","title":"Moving on After Breast Cancer Trial for Depressed Breast Cancer Survivors in Pakistan","status":"RECRUITING","sponsor":"Pakistan Institute of Living and Learning","startDate":"2025-06-13","conditions":"Major Depressive Disorder (MDD), Breast Cancer Survivor","enrollment":26376},{"nctId":"NCT05964010","phase":"NA","title":"Primary Connections for Youth and Families","status":"RECRUITING","sponsor":"The National Center on Addiction and Substance Abuse at Columbia University","startDate":"2024-03-01","conditions":"Substance Use","enrollment":2300},{"nctId":"NCT07204184","phase":"NA","title":"Multisite Transspinal Stimulation for Augmenting Recovery in Spinal Cord Injury","status":"RECRUITING","sponsor":"Maria Knikou, PT, MBA, PhD","startDate":"2026-02-19","conditions":"Spinal Cord Injuries (Complete and Incomplete)","enrollment":36},{"nctId":"NCT04594642","phase":"PHASE1","title":"A Study of AZD0486 in Subjects With B-Cell Non-Hodgkin Lymphoma","status":"RECRUITING","sponsor":"AstraZeneca","startDate":"2021-03-02","conditions":"B-cell Non Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, High-grade B-cell Lymphoma","enrollment":317},{"nctId":"NCT05832112","phase":"NA","title":"Outside the Cage (OTC) Robotic Lobectomy","status":"ACTIVE_NOT_RECRUITING","sponsor":"Centre hospitalier de l'Université de Montréal (CHUM)","startDate":"2023-02-22","conditions":"Lung Cancer Stage I","enrollment":100},{"nctId":"NCT07477951","phase":"NA","title":"The Impact of Automatic Lung Recruitment Postoperative Pulmonary Complications","status":"NOT_YET_RECRUITING","sponsor":"Yongtao Sun","startDate":"2026-04-01","conditions":"Acute Lung Injury","enrollment":58},{"nctId":"NCT07246057","phase":"NA","title":"Streamlining Telehealth for Expanded PrEP Utilization Through Community Partnerships","status":"NOT_YET_RECRUITING","sponsor":"University of Pennsylvania","startDate":"2026-02","conditions":"HIV","enrollment":92},{"nctId":"NCT07476482","phase":"NA","title":"The Impact of a Shared Decision-Making Intervention on Intraoperative Patient Experience During Elective Cesarean Delivery Under Spinal Anesthesia","status":"ENROLLING_BY_INVITATION","sponsor":"Alexandria University","startDate":"2026-04-01","conditions":"Decision Making , Cesarean Section","enrollment":80},{"nctId":"NCT06671587","phase":"PHASE4","title":"iGlarLixi CGM Study in Chinese T2D Individuals After OADs","status":"RECRUITING","sponsor":"Sanofi","startDate":"2024-12-10","conditions":"Type 2 Diabetes (T2D)","enrollment":678},{"nctId":"NCT06353022","phase":"PHASE2","title":"Minimal Residual Disease-based Strategy With T-Cell Redirector After Treatment With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone (D-VRd) in Newly Diagnosed Multiple Myeloma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Nantes University Hospital","startDate":"2024-06-26","conditions":"Multiple Myeloma","enrollment":103},{"nctId":"NCT06916806","phase":"PHASE1","title":"A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.","status":"RECRUITING","sponsor":"AstraZeneca","startDate":"2025-05-01","conditions":"Systemic Lupus Erythematosus, Idiopathic Inflammatory Myopathies, Rheumatoid Arthritis","enrollment":72},{"nctId":"NCT07041736","phase":"NA","title":"Evaluating Postoperative Pain and Antibacterial Effect of Ultrasonic and 980 nm Diode Laser Combination","status":"RECRUITING","sponsor":"Al-Azhar University","startDate":"2025-08-03","conditions":"Post Operative Pain","enrollment":120},{"nctId":"NCT07133555","phase":"NA","title":"Safe Spaces 4 Sexual Health","status":"RECRUITING","sponsor":"Johns Hopkins University","startDate":"2025-08-10","conditions":"HIV Counseling and Testing, HIV Risk Behavior, HIV Prevention","enrollment":100},{"nctId":"NCT06252220","phase":"PHASE1","title":"First in Human Study in Subjects With Obesity, But Otherwise Healthy","status":"RECRUITING","sponsor":"NeuroBo Pharmaceuticals Inc.","startDate":"2024-03-25","conditions":"Obesity","enrollment":139},{"nctId":"NCT07472283","phase":"","title":"Design, Development and Evaluation of a Digital Health Assistant for Paediatric Asthma","status":"NOT_YET_RECRUITING","sponsor":"University Children's Hospital Basel","startDate":"2026-04","conditions":"Paediatric Asthma","enrollment":42},{"nctId":"NCT06730204","phase":"NA","title":"Standardized Nutritional Management of Pediatric Patients With Solid Tumors","status":"RECRUITING","sponsor":"Children's Hospital of Fudan University","startDate":"2023-07-01","conditions":"Tumor, Solid, Children, Nutritional Intervention","enrollment":400},{"nctId":"NCT07475481","phase":"NA","title":"Exercise-Based Strategies for Chronic Back Pain","status":"NOT_YET_RECRUITING","sponsor":"Charles University, Czech Republic","startDate":"2027-07-01","conditions":"Chronic Low-back Pain (cLBP)","enrollment":120},{"nctId":"NCT07472374","phase":"PHASE3","title":"Functional Restoration for Chronic Low Back Pain: Medico-economic Impact","status":"NOT_YET_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2026-03-10","conditions":"Nonspecific Chronic Low Back Pain With Work Disability","enrollment":242},{"nctId":"NCT07474090","phase":"NA","title":"Personalized Exercise Program for Survivors of Breast Cancer, STEPS-BC Trial","status":"NOT_YET_RECRUITING","sponsor":"Wake Forest University Health Sciences","startDate":"2026-07-05","conditions":"Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8","enrollment":120},{"nctId":"NCT07240727","phase":"NA","title":"The Effect of Role Differences on Learning and Self-Assessment in Simulation-Based Life Support Training Among Dental Students","status":"COMPLETED","sponsor":"Gözde Nur Erkan","startDate":"2025-11-20","conditions":"Intermediate Life Support, Dental Students, Self Evaluation","enrollment":106},{"nctId":"NCT07299695","phase":"PHASE3","title":"Intravenous Immunoglobulin for the Treatment of Acute Exacerbations of Idiopathic Pulmonary Fibrosis","status":"RECRUITING","sponsor":"Argyrios Tzouvelekis","startDate":"2026-01-25","conditions":"Idiopathic Pulmonary Fibrosis, Acute Exacerbation of Idiopathic Pulmonary Fibrosis","enrollment":196},{"nctId":"NCT06411769","phase":"NA","title":"Evidence-based Intervention to Improve Walking Engagement in El Paso, Texas","status":"RECRUITING","sponsor":"University of Texas, El Paso","startDate":"2024-09-01","conditions":"Activity Trackers, Physical Activity","enrollment":406},{"nctId":"NCT07105007","phase":"NA","title":"Proof-of-concept of a Behavioral Intervention to Improve the Cardiovascular Health of People Living With HIV","status":"RECRUITING","sponsor":"University of Washington","startDate":"2025-08-15","conditions":"HIV, Heart Failure","enrollment":30}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[{"date":"20150413","type":"SUPPL","sponsor":"DIFGEN PHARMS","applicationNumber":"ANDA074612"},{"date":"20071030","type":"SUPPL","sponsor":"DIFGEN PHARMS","applicationNumber":"ANDA074612"},{"date":"20000215","type":"SUPPL","sponsor":"DIFGEN PHARMS","applicationNumber":"ANDA074612"},{"date":"19990524","type":"SUPPL","sponsor":"DIFGEN PHARMS","applicationNumber":"ANDA074612"},{"date":"19990524","type":"SUPPL","sponsor":"DIFGEN PHARMS","applicationNumber":"ANDA074612"},{"date":"19971020","type":"ORIG","sponsor":"DIFGEN PHARMS","applicationNumber":"ANDA074612"},{"date":"20100216","type":"SUPPL","sponsor":"DIFGEN PHARMS","applicationNumber":"ANDA074612"},{"date":"20020227","type":"SUPPL","sponsor":"DIFGEN PHARMS","applicationNumber":"ANDA074612"},{"date":"20000215","type":"SUPPL","sponsor":"DIFGEN PHARMS","applicationNumber":"ANDA074612"},{"date":"19990524","type":"SUPPL","sponsor":"DIFGEN PHARMS","applicationNumber":"ANDA074612"},{"date":"19990524","type":"SUPPL","sponsor":"DIFGEN PHARMS","applicationNumber":"ANDA074612"},{"date":"19991112","type":"SUPPL","sponsor":"DR REDDYS LABS SA","applicationNumber":"NDA020076"},{"date":"20160119","type":"SUPPL","sponsor":"DR REDDYS LABS SA","applicationNumber":"NDA020076"},{"date":"20140725","type":"SUPPL","sponsor":"DR REDDYS LABS SA","applicationNumber":"NDA020076"},{"date":"19960724","type":"SUPPL","sponsor":"DR REDDYS LABS SA","applicationNumber":"NDA020076"},{"date":"20051122","type":"SUPPL","sponsor":"DR REDDYS LABS SA","applicationNumber":"NDA020076"},{"date":"20160706","type":"SUPPL","sponsor":"DR REDDYS LABS SA","applicationNumber":"NDA020076"},{"date":"19960208","type":"SUPPL","sponsor":"DR REDDYS LABS SA","applicationNumber":"NDA020076"},{"date":"20160509","type":"SUPPL","sponsor":"DR REDDYS LABS SA","applicationNumber":"NDA020076"},{"date":"20001107","type":"SUPPL","sponsor":"DR REDDYS LABS SA","applicationNumber":"NDA020076"},{"date":"20040206","type":"SUPPL","sponsor":"DR REDDYS LABS SA","applicationNumber":"NDA020076"},{"date":"19920721","type":"SUPPL","sponsor":"DR REDDYS LABS SA","applicationNumber":"NDA020076"},{"date":"19920106","type":"SUPPL","sponsor":"DR REDDYS LABS SA","applicationNumber":"NDA020076"},{"date":"19981029","type":"SUPPL","sponsor":"DR REDDYS LABS SA","applicationNumber":"NDA020076"},{"date":"20020712","type":"SUPPL","sponsor":"DR REDDYS LABS SA","applicationNumber":"NDA020076"},{"date":"19951006","type":"SUPPL","sponsor":"DR REDDYS LABS SA","applicationNumber":"NDA020076"},{"date":"20180627","type":"SUPPL","sponsor":"DR REDDYS LABS SA","applicationNumber":"NDA020076"},{"date":"20160404","type":"SUPPL","sponsor":"DR REDDYS LABS SA","applicationNumber":"NDA020076"},{"date":"20170723","type":"SUPPL","sponsor":"DR REDDYS LABS SA","applicationNumber":"NDA020076"},{"date":"19911127","type":"ORIG","sponsor":"DR REDDYS LABS SA","applicationNumber":"NDA020076"},{"date":"20151117","type":"SUPPL","sponsor":"DR REDDYS LABS SA","applicationNumber":"NDA020076"},{"date":"20190102","type":"SUPPL","sponsor":"DR REDDYS LABS SA","applicationNumber":"NDA020076"},{"date":"20060505","type":"SUPPL","sponsor":"DR REDDYS LABS SA","applicationNumber":"NDA020076"},{"date":"20160705","type":"SUPPL","sponsor":"DR REDDYS LABS SA","applicationNumber":"NDA020076"},{"date":"20130516","type":"SUPPL","sponsor":"DR REDDYS LABS SA","applicationNumber":"NDA020076"},{"date":"20041021","type":"SUPPL","sponsor":"DR REDDYS LABS SA","applicationNumber":"NDA020076"},{"date":"20160510","type":"SUPPL","sponsor":"DR REDDYS LABS SA","applicationNumber":"NDA020076"},{"date":"19941006","type":"SUPPL","sponsor":"DR REDDYS LABS SA","applicationNumber":"NDA020076"},{"date":"20040121","type":"SUPPL","sponsor":"DR REDDYS LABS SA","applicationNumber":"NDA020076"},{"date":"20000131","type":"SUPPL","sponsor":"DR REDDYS LABS SA","applicationNumber":"NDA020076"},{"date":"19920721","type":"SUPPL","sponsor":"DR REDDYS LABS SA","applicationNumber":"NDA020076"},{"date":"19991203","type":"SUPPL","sponsor":"DR REDDYS LABS SA","applicationNumber":"NDA020076"},{"date":"20020715","type":"SUPPL","sponsor":"DR REDDYS LABS SA","applicationNumber":"NDA020076"},{"date":"19990107","type":"SUPPL","sponsor":"DR REDDYS LABS SA","applicationNumber":"NDA020076"}],"publicationCount":4958,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Step 1","genericName":"Step 1","companyName":"Green Cross Corporation","companyId":"green-cross-corporation","modality":"Biologic","firstApprovalDate":"","aiSummary":"Step 1 is a recombinant human insulin used to lower blood glucose levels in people with diabetes. Used for Diabetes mellitus, type 1, Diabetes mellitus, type 2.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}